Patent · US Active

Pharmaceutical device for use in intranasal administration

US12303472B2 · kind B2 · utility

1Cited by
22References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 24, 2023
Grant dateMay 20, 2025
Priority date
Expiry dateMay 24, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2202/064
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a needle-free applicator that is suitable for administering a solid, amorphous, mono-particulate powder composition into a body cavity of a human patient, which cavity includes a mucosal surface, wherein the applicator comprises:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.